(NASDAQ:KUST),(NasdaqGM:CYCU), COMPANY ACCELERATES STRATEGIC PIVOT TO PURE-PLAY ENETERTAINMENT MODEL OVERLAND PARK, KS, Feb. 10, 2026 (GLOBE NEWSWIRE) — Kustom Entertainment, Inc. (Nasdaq: KUST) (“Kustom Entertainment” or the “Company”), a leader in live event production and online ticketing, today announced that its subsidiary, TicketSmarter, Inc. has been named one of the 10 Best Ticket Resale Sites […]

Zinzino is pleased to announce that it will launch its operations in Peru on February 10th, 2026. Zinzino continues to strengthen its presence in Latin America with the launch of operations in Peru, which has generated monthly sales of approximately SEK 1.5 million through the company's global web shop. The expansion builds on the company's

KUSTOM ENTERTAINMENT'S TICKETSMARTER NAMED AMONG “10 BEST TICKET RESALE SITES OF 2026” BY FORBES ADVISOR GlobeNewswire February 10, 2026 COMPANY ACCELERATES STRATEGIC PIVOT TO PURE-PLAY ENETERTAINMENT MODEL OVERLAND PARK, KS, Feb. 10, 2026 (GLOBE NEWSWIRE) — Kustom Entertainment, Inc. (Nasdaq: KUST) (“Kustom Entertainment” or the “Company”), a leader in live event production and online ticketing,

Tegavivint Is the First Wnt/B-Catenin Inhibitor to Demonstrate Tolerability and Monotherapy Clinical Activity in Complex Solid Tumors Osteosarcoma Program Builds on Clinical Benefit observed in Lead Indication of Advanced Hepatocellular Carcinoma Iterion Therapeutics, a clinical-stage, biopharmaceutical company dedicated to revolutionizing the treatment of Wnt-driven cancers, today announced that the first patient has been dosed in

(NASDAQ:VCIG), KUALA LUMPUR, Malaysia, Feb. 10, 2026 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced that Reveillon Champ Sdn Bhd (“Reveillon Champ”), a subsidiary of VCI Global's portfolio company Reveillon Group Limited (“Reveillon Group”), has entered a strategic cooperation with NOWWA Global HK Limited (“NOWWA Coffee”) to develop

(NASDAQ:MYSE), NEW BRUNSWICK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) — Myseum, Inc. (Nasdaq: MYSE) (“Myseum” or the “Company”), a privacy-first social media and technology innovator, today issued a shareholder letter by CEO Darin Myman detailing the Company's plans for revenue generation, developing Picture Party by Myseum (“Picture Party”) for influencers, continuing the development of its

Advancing development of lead candidate BT-101, a potential disease-modifying treatment for Brittle Bone Disease Preparing for Phase III development following promising data showing reduced fractures in affected children STOCKHOLM, Feb. 10, 2026 (GLOBE NEWSWIRE) — BOOST Pharma (“BOOST” or the “Company), a clinicalâ€'stage biopharmaceutical company developing novel, firstâ€'inâ€'class off-the-shelf cell therapies for rare, debilitating pediatric

Hans Schambye Appointed as Chief Executive Officer of BOOST Pharma GlobeNewswire February 10, 2026 Advancing development of lead candidate BT-101, a potential disease-modifying treatment for Brittle Bone Disease Preparing for Phase III development following promising data showing reduced fractures in affected children STOCKHOLM, Feb. 10, 2026 (GLOBE NEWSWIRE) — BOOST Pharma (“BOOST” or the “Company),

VCI Global's Portfolio Company Reveillon Group Enters Strategic Cooperation with NOWWA Coffee to Develop the Malaysian Market Global Coffee Brand with 10,000+ Stores Worldwide Targets Scalable Expansion in Southeast Asia GlobeNewswire February 10, 2026 KUALA LUMPUR, Malaysia, Feb. 10, 2026 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced

Myseum Highlights Monetization Strategy, Influencer Platform and New Safe Social Media Technology in Letter to Shareholders GlobeNewswire February 10, 2026 NEW BRUNSWICK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) — Myseum, Inc. (Nasdaq: MYSE) (“Myseum” or the “Company”), a privacy-first social media and technology innovator, today issued a shareholder letter by CEO Darin Myman detailing the